Physician profile
James Cooper
NPI 1346400405
$2,528.86
in general payments reported to CMS, 2019-2025
16 companies · $711 in 2025
The $711 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $76.48 · 2021: $261 · 2022: $514 · 2023: $194 · 2024: $613 · 2025: $711.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,517.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,215.38 | 2021-2025 | Mazor X System, Unid_pass, Intellis Adaptivestim |
| Zimmer Biomet Holdings, INC. | $245.73 | 2021 | |
| Providence Medical Technology, INC. | $186.83 | 2024-2025 | |
| Merz North America, INC. | $172.97 | 2022 | |
| Si-Bone, INC. | $166.49 | 2022 | |
| Medtronic USA, INC. | $147.59 | 2019-2020 | |
| Globus Medical, INC. | $93.68 | 2024-2025 | Rise, Reline, Simplify Cervical Artificial Disc |
| Stryker Corporation | $65.00 | 2020 | |
| Centinel Spine, LLC | $46.60 | 2025 | Prodisc C Sk |
| Pylant Medical | $45.19 | 2024 | |
| Cerapedics INC. | $38.77 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Arteriocyte Medical Systems, INC. | $30.59 | 2023-2024 | Magellan |
| Nuvasive, INC. | $23.93 | 2019 | |
| Integra Lifesciences Corporation | $20.44 | 2024 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Hakim |
| Alafair Biosciences, INC. | $15.89 | 2025 | Versawrap |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $13.78 | 2024 | Ha Minuteman G3-R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.